Want to see HK:0922 full AI Analyst Report?
Top Page
Anxian Yuan China Holdings Limited
(0922)
Select Model
Select Model
Rating:51Neutral
Price Target:
HK$0.10
▼(-11.82% Downside)
Action:Reiterated
Date:10/11/26
The score is held back mainly by deteriorating operating performance (multi-year revenue decline and a swing to a net loss) and weak technical trend signals (below major moving averages with negative MACD). Support comes from a conservatively financed balance sheet and positive/free cash flow improvement, plus a very high dividend yield, though losses make valuation signals less reliable.
Positive Factors
Conservative balance sheet
Very low leverage gives the company financial flexibility while reducing interest and refinancing pressure. A sizable equity base and stable assets provide a stronger foundation for sustaining cemetery operations, funding required projects, and managing a prolonged period of weaker profitability.
Negative Factors
Multi-year revenue contraction
Repeated revenue contraction points to sustained pressure on demand, pricing, or product mix rather than a single-period fluctuation. Prolonged top-line weakness can reduce operating leverage, limit reinvestment capacity, and make future earnings recovery less predictable.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low leverage gives the company financial flexibility while reducing interest and refinancing pressure. A sizable equity base and stable assets provide a stronger foundation for sustaining cemetery operations, funding required projects, and managing a prolonged period of weaker profitability.
Read all positive factors
Anxian Yuan China Holdings Limited (0922) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$215.47M
Dividend Yield16.49%
Average Volume (3M)392.20K
Price to Earnings (P/E)―
Beta (1Y)0.09
Revenue Growth-16.99%
EPS Growth-326.96%
CountryHK
Employees193
SectorConsumer Cyclical
Sector Strength84
IndustryPersonal Products & Services
Share Statistics
EPS (TTM)-0.05
Shares Outstanding2,221,363,000
10 Day Avg. Volume391,800
30 Day Avg. Volume392,200
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.35
Price to Sales (P/S)1.51
P/FCF Ratio7.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Anxian Yuan China Holdings Limited Business Overview & Revenue Model
Company Description
Anxian Yuan China Holdings Limited is an investment holding enterprise primarily engaged in the cemetery industry across the People's Republic of China. The company's services include offering funeral and burial arrangements, as well as the sale o...
How the Company Makes Money
Revenue is primarily generated through (1) the sale of cemetery plots (burial rights) to customers, which typically represents the core income stream for cemetery operators; (2) fees from interment and other cemetery service charges associated wit...
Anxian Yuan China Holdings Limited Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
78
Positive
Cash Flow
66
Positive
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 196.25M | 236.43M | 284.43M | 340.53M | 310.95M |
| Gross Profit | 123.00M | 172.98M | 207.73M | 251.41M | 220.18M |
| EBITDA | 41.12M | 98.85M | 109.34M | 169.84M | 135.67M |
| Net Income | -115.90M | 51.08M | 57.82M | 104.92M | 73.13M |
Balance Sheet | |||||
| Total Assets | 1.29B | 1.28B | 1.28B | 1.33B | 1.34B |
| Cash, Cash Equivalents and Short-Term Investments | 210.71M | 329.70M | 339.43M | 340.53M | 209.87M |
| Total Debt | 34.52M | 44.59M | 17.74M | 45.27M | 49.45M |
| Total Liabilities | 419.84M | 309.91M | 296.46M | 325.89M | 335.74M |
| Stockholders Equity | 835.43M | 937.65M | 942.97M | 970.33M | 965.29M |
Cash Flow | |||||
| Free Cash Flow | 38.42M | 67.51M | 84.81M | 184.43M | 66.84M |
| Operating Cash Flow | 43.99M | 72.45M | 91.64M | 186.51M | 69.14M |
| Investing Cash Flow | -82.70M | -129.85M | 57.77M | -60.79M | -2.63M |
| Financing Cash Flow | -39.89M | -12.69M | -79.74M | -33.65M | -131.30M |
Anxian Yuan China Holdings Limited Technical Analysis
Negative
0.11
Price Trends
0.10
Negative
0.11
Negative
0.12
Negative
Market Momentum
>-0.01
Negative
45.13
Neutral
12.50
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0922, the sentiment is Negative. The current price of 0.11 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.10, and below the 200-day MA of 0.12, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 45.13 is Neutral, neither overbought nor oversold. The STOCH value of 12.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0922.
Anxian Yuan China Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$1.48B | 8.29 | 43.78% | 12.33% | -14.68% | -13.60% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | HK$6.03B | 14.06 | 6.50% | 20.98% | ― | ― | |
51 Neutral | HK$215.47M | -1.86 | -13.22% | 16.49% | -16.99% | -326.96% | |
50 Neutral | HK$72.36M | -40.00 | -0.93% | 6.43% | -2.31% | 66.07% | |
43 Neutral | HK$14.84M | -0.63 | -17.95% | ― | -26.00% | -188.55% | |
41 Neutral | HK$1.02B | -32.69 | -11.19% | ― | -31.52% | -240.59% |
* Consumer Cyclical Sector Average
HK:0922
Anxian Yuan China Holdings Limited
0.10
-0.06
-36.60%
HK:1448
Fu Shou Yuan International Group
2.64
-0.11
-3.83%
HK:0919
Modern Healthcare Technology Holdings Limited
0.08
<0.01
8.11%
HK:1027
China Jicheng Holdings Limited
2.44
-2.02
-45.29%
HK:1830
Perfect Medical Health Management Limited
1.18
-0.14
-10.74%
HK:8296
Sino-Life Group Limited
0.16
-0.22
-58.68%
Anxian Yuan China Holdings Limited Corporate Events
Anxian Yuan China Wins Full Shareholder Backing at 2026 AGM
Sep 7, 2026
Shareholders of Anxian Yuan China Holdings Limited have unanimously approved all resolutions at the annual general meeting held on 7 September 2026 in Hong Kong. The meeting confirmed the adoption of the group’s audited financial statements ...
Anxian Yuan China Adjusts Registered Office Address in Bermuda
Jul 27, 2026
Anxian Yuan China Holdings Limited is a Bermuda-incorporated company listed on the Hong Kong Stock Exchange under stock code 00922, with cross-border corporate arrangements that include Tricor Investor Services Limited serving as its branch share ...
Anxian Yuan China Sets 2026 AGM to Renew Mandates and Share-Issue Authority
Jul 23, 2026
Anxian Yuan China Holdings has convened its annual general meeting for 7 September 2026 in Hong Kong, where shareholders will review the audited consolidated financial statements for the year ended 31 March 2026 and consider re-election of directo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.